More in Cardiovascular

  • Jan 17, 2012
    blog

    Terumo acquires Onset Medical for access sheath technology

    Terumo Americas Holding (TAH), Inc , a U.S. subsidiary of Japan's Terumo Corp, has acquired Onset Medical Corp, an innovative medical device company located in Irvine, CA, that focuses on developing first-in-class access sheath technology designed for ......More
  • Nov 1, 2011
    blog

    Cardio care? Yes, there's an app for that

    Boston Scientific Corp. has introduced an iPad app. Called CardioTeach, the app is an industry-first, free educational resource to help healthcare professionals better educate patients and caregivers about therapy options related to cardiovascular and ......More
  • Oct 18, 2011
    blog

    FDA proposes lower risk classification, special controls for external pacemakers

    FDA has issued a proposed rule and draft special controls guidance lowering the risk classification for external pacemaker pulse generators from Class III (high-risk) to Class II (moderate-risk). External pacemaker pulse generators are used ......More
  • Apr 11, 2011
    blog

    China's cardiac device market to nearly double by 2015

    Greater healthcare expenditure supported by robust economic growth will lead to nearly 13% annual growth in the market for pacemakers, implantable cardioverter defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices in China, according ......More
  • Mar 4, 2011
    blog

    Boston Scientific acquires another innovative company

    Boston Scientific Corp appears to be this year's acquisition leader. It has just announced the completion of yet another acquisition on a quest to round out its portfolio. Atritech's Watchman left atrial appendage closure technology gives Boston ......More
  • Mar 1, 2011
    blog

    Medtronic diabetes pump to be used for delivering peptide to heart patients

    Nile Therapeutics Inc.  announced plans to collaborate with Medtronic Inc.on the clinical development of Nile's proprietary natriuretic peptide, cenderitide (formerly CD-NP), for heart failure and renal disease applications. Nile focuses on the ......More
  • Feb 22, 2011
    blog

    UK's NHS launches competition seeking cardio innovations to improve healthcare

    TrusTech, an arm of the UK's National Health System, has recently launched a Smart Solutions program that will look for companies with new technologies, services, or other innovations that could help improve the quality of healthcare for patients with ......More
  • Jan 4, 2011
    blog

    Boston Scientific says ICD data 'out of context' in JAMA article

    Boston Scientific's chief medical officer for cardiac rhythm management issued a statement today calling the findings of a recent JAMA editorial "out of context." In addition to noting that not only did the article fail to explain the data properly, it ......More

Sponsored Introduction Continue on to (or wait seconds) ×